Last reviewed · How we verify
placebo tablet of DLBS1033
placebo tablet of DLBS1033 is a Small molecule drug developed by Dexa Medica Group. It is currently FDA-approved. Also known as: placebo tablet of Disolf.
A placebo tablet containing no active pharmaceutical ingredient, used as a control comparator in clinical trials.
At a glance
| Generic name | placebo tablet of DLBS1033 |
|---|---|
| Also known as | placebo tablet of Disolf |
| Sponsor | Dexa Medica Group |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebo tablets are inert formulations designed to match the appearance and administration of an active drug while containing no therapeutic agent. They serve as the control arm in randomized controlled trials to measure the true efficacy of an investigational drug by accounting for placebo effect and natural disease progression. DLBS1033 placebo is manufactured by Dexa Medica Group for use in clinical studies of the active DLBS1033 formulation.
Approved indications
Common side effects
Key clinical trials
- Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes (PHASE4)
- DLBS1033 for Acute Ischemic Stroke Patients (PHASE2, PHASE3)
- Effect of DLBS1033 After Primary PCI in Patients With STE-ACS (PHASE2, PHASE3)
- DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease (PHASE2, PHASE3)
- The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers (PHASE2)
- DLBS1033 for the Treatment of Acute Ischemic Stroke (PHASE3)
- Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus (PHASE4)
- DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- placebo tablet of DLBS1033 CI brief — competitive landscape report
- placebo tablet of DLBS1033 updates RSS · CI watch RSS
- Dexa Medica Group portfolio CI
Frequently asked questions about placebo tablet of DLBS1033
What is placebo tablet of DLBS1033?
How does placebo tablet of DLBS1033 work?
Who makes placebo tablet of DLBS1033?
Is placebo tablet of DLBS1033 also known as anything else?
What development phase is placebo tablet of DLBS1033 in?
Related
- Manufacturer: Dexa Medica Group — full pipeline
- Also known as: placebo tablet of Disolf
- Compare: placebo tablet of DLBS1033 vs similar drugs
- Pricing: placebo tablet of DLBS1033 cost, discount & access